News briefing: Ovid shows mixed results on epilepsy program; Iliad reports positive whooping cough data
Ovid Therapeutics $OVID announced Wednesday mixed results of a Phase II study in a program seeking to treat rare epilepsies.
The 20-patient trial, which was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
